New combo attack aims to shrink liver tumors for surgery
NCT ID NCT07179900
Summary
This study is testing if adding a targeted radiation treatment (radiotherapy) to a two-drug therapy helps shrink liver tumors in patients whose cancer cannot be removed by surgery initially. The goal is to see if this combination can shrink the tumors enough to make surgery possible later. Researchers will compare the new combination to the standard two-drug therapy alone in 60 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.